US sets policy to seize patents of government-funded drugs if price deemed too high
Isabelle Lawler, a pharmacy student, answers calls at Skippack Pharmacy in Schwenksville, Pennsylvania, U.S., February 26, 2021. Picture taken February...
archiveHECA
Global banks forecast improved investment banking outlook
A street sign for Wall Street hangs in front of the New York Stock Exchange May 8, 2013. REUTERS/Lucas Jackson/File Photo Acquire Licensing RightsNEW YORK, Dec 5 (Reuters) - Global bank executives said that dealmaking conditions have begun to improve, with some predicting a better outlook for strategic mergers and acquisitions at an industry event on Tuesday.Both M&A activity and initial public offerings (IPOs) faltered last year after Russia's invasion of Ukraine and the U.S. Federal Reserve's aggressive rate hikes to tame inflation."The M&A deals are coming a little faster,"...
EU extends decision date on Novoyzmes, Chr. Hansen deal to Dec. 12
A view of a facility of biotechnology company Chr. Hansen, a global company that manufactures ingredients for the food industry,...
European shares end the week higher as bond yields slide on rate cut bets
A TV presenter gets ready for the daily reporting from the floor of the German share price index DAX at the stock exchange in Frankfurt, Germany, November 15, 2023. REUTERS/Staff/File Photo Acquire Licensing RightsMarkets price in 100-bps rate cuts in 2024Moody's Italy rating review dueVolvo Cars shares drop to record low as Geely trims stakeSTOXX 600 up 1.0%, adds 2.8% this weekNov 17 (Reuters) - European shares rose on Friday, boosted by financials and healthcare, ending the week higher on growing optimism that central banks will aggressively cut interest rates...
France eyes cuts to business subsidies and healthcare spending
A view shows skyscraper office properties at La Defense business and financial district near Paris, France, June 26, 2023. REUTERS/Stephanie...
Novo Nordisk invests $6 bln in Wegovy production, still far below demand -CEO
The logo of Danish drugmaker Novo Nordisk, Copenhagen, Denmark, September 26, 2023. REUTERS/Tom Little/File Photo Acquire Licensing RightsLONDON/COPENHAGEN, Nov 10 (Reuters) - Obesity drug maker Novo Nordisk (NOVOb.CO) said on Friday it will spend $6 billion to boost production in Denmark, although its chief executive warned the industry was far from being able to produce enough weight-loss drugs to meet global demand.Novo Nordisk has had phenomenal success with its anti-obesity drug, Wegovy, but has scrambled to address shortages that have forced it to limit the number of patients.The World Health...
Wall St rallies 1%, yen gains vs dollar; talk of BOJ policy tweak
Major U.S. stock indexes end more than 1% higherOil prices fall as investors monitor Mideast developmentsFed, BoE and BOJ all...
Morning Bid: Big Tech reports as bond yields recoil
A look at the day ahead in U.S. and global markets from Mike DolanBig Tech heavyweights Microsoft (MSFT.O) and Alphabet...
Gold rally cools as traders eye MidEast developments, US data
Markets await US PCE price index, Q3 GDP data this weekPalladium up 3%Oct 23 (Reuters) - Safe-haven gold eased on Monday, hitting pause after jumping to within striking distance of the key $2,000 level in the last session, as traders positioned for further developments on the Middle East conflict and U.S. economic data.Spot gold fell 0.3% to $1,976.19 per ounce by 1:41 p.m. ET (1741 GMT). U.S. gold futures settled 0.3% lower at $1,987.80.Reuters Graphics"Safe-haven demand will continue to drive gold higher after a slight period of consolidation. We believe...
S&P 500, Nasdaq fall with data, geopolitics offsets strong results
JPMorgan and Wells Fargo, rise on Q3 profit beatS&P 500, Dow notch weekly gains, U.S. crude prices rallyU Mich's preliminary...
